TD Cowen Maintains Buy on Abbott Laboratories, Lowers Price Target to $118

Benzinga · 3d ago
TD Cowen analyst Joshua Jennings maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $118.